Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes

Huili Li(Penn State Milton S. Hershey Medical Center), Guoli Chen(Geisinger Medical Center)
Scientific Reports
January 29, 2020
Cited by 59


Related Papers